Drugs.com - Clinical Trials

Phase 3 Clinical Study of Mazdutide in Chinese Adults with Overweight or Obesity (GLORY-1) Published in The New England Journal of Medicine (NEJM)

SAN FRANCISCO, U.S., SUZHOU, China May 26, 2025 – Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment...

May 26, 2025 - 06:50
 0
Phase 3 Clinical Study of Mazdutide in Chinese Adults with Overweight or Obesity (GLORY-1) Published in The New England Journal of Medicine (NEJM)
SAN FRANCISCO, U.S., SUZHOU, China May 26, 2025 – Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment...
Read More

Tags:

Previous Article

Superdrug Launches LGBTQIA+ Charity Checkout Initiative

Next Article

Savara Presented New Data From Pivotal Phase 3 IMPALA-2 Trial of Molgramostim In...

Related Posts

Apnimed Announces Positive Topline Results in the First Landmark Phase 3 Clinical Trial of AD109, an Investigational Once-Daily Oral Pill for Obstructive Sleep Apnea

Apnimed Announces Positive Topline Results in the First...

May 20, 2025  0

Johnson & Johnson’s TAR-200 Monotherapy Demonstrates Highest Complete Response Rate with Sustained Clinical Benefits in Patients with Certain Types of Bladder Cancer

Johnson & Johnson’s TAR-200 Monotherapy Demonstrates Hi...

May 12, 2025  0

The New England Journal of Medicine Publishes Data from Phase 2b Trial of Oral Orexin Receptor 2 Agonist Oveporexton (TAK-861) in People with Narcolepsy Type 1

The New England Journal of Medicine Publishes Data from...

May 15, 2025  0